XML 39 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Quarterly Financial Data - Unaudited
12 Months Ended
Oct. 01, 2022
Quarterly Financial Data - Unaudited  
Quarterly Financial Data - Unaudited

Note 20. Quarterly Financial Data – Unaudited

The following tables set forth selected unaudited quarterly financial information for the years ended October 1, 2022 and October 2, 2021. As described in Note 2, the Company has restated its unaudited quarterly financial information for each of the interim periods in the years ended October 1, 2022 and October 2, 2021. This information has been prepared on the same basis as the unaudited consolidated financial statements. The adjustments to the unaudited quarterly financial information below are the same as the Investigation Adjustments and Other Adjustments discussed in Note 2.

    

As Restated

 

Year ended October 1, 2022

 

    

First Quarter

    

Second Quarter

    

Third Quarter

    

Fourth Quarter

 

(In thousands, except per share data)

 

Net sales

$

1,756,326

$

1,915,070

$

2,023,361

$

2,224,865

Gross profit

$

141,297

$

146,495

$

162,185

$

172,229

Gross margin

 

8.0

%  

 

7.6

%  

 

8.0

%  

 

7.7

%

Operating income

$

78,241

$

76,274

$

91,614

$

103,350

Operating margin

 

4.5

%  

 

4.0

%  

 

4.5

%  

 

4.6

%

Net income

$

56,177

$

48,621

$

77,222

$

58,364

Basic net income per share

$

0.87

$

0.77

$

1.29

$

1.01

Diluted net income per share

$

0.85

$

0.76

$

1.25

$

0.98

As Restated

 

Year ended October 2, 2021

 

    

First Quarter

    

Second Quarter

    

Third Quarter

    

Fourth Quarter

    

(In thousands, except per share data)

 

Net sales

$

1,755,984

$

1,678,497

$

1,653,266

$

1,650,609

Gross profit

$

140,351

$

120,985

$

135,066

$

130,039

Gross margin

 

8.0

%  

 

7.2

%  

 

8.2

%  

 

7.9

%

Operating income

$

74,675

$

42,610

$

72,741

$

65,910

Operating margin

 

4.3

%  

 

2.5

%  

 

4.4

%  

 

4.0

%

Net income

$

49,558

$

27,868

$

116,195

$

55,925

Basic net income per share

$

0.76

$

0.43

$

1.78

$

0.86

Diluted net income per share

$

0.74

$

0.42

$

1.73

$

0.83

Consolidated Balance Sheets

The following table presents the impact of the financial statement adjustments on the Company’s previously reported Consolidated Balance Sheets as of January 1, 2022, April 2, 2022 and July 2, 2022.

As of

January 1, 2022

April 2, 2022

July 2, 2022

Previously 

Investigation

Other

Previously 

Investigation

Other

Previously 

Investigation

Other

    

Reported

    

Adjustments

    

Adjustments

    

As Restated

    

Reported

    

Adjustments

    

Adjustments

    

As Restated

    

Reported

    

Adjustments

    

Adjustments

    

As Restated

(Unaudited) (In thousands)

ASSETS

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Current assets:

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Cash and cash equivalents

$

627,717

$

$

$

627,717

$

559,893

$

$

$

559,893

$

493,305

$

$

$

493,305

Accounts receivable, net of allowances

 

1,298,327

 

 

687

 

1,299,014

 

1,270,494

 

 

606

 

1,271,100

 

1,228,435

 

 

1,429

 

1,229,864

Contract assets

 

364,407

 

(31,772)

 

14,948

 

347,583

 

417,286

 

(33,512)

 

15,508

 

399,282

 

459,306

 

(34,918)

 

20,408

 

444,796

Inventories

 

1,242,440

 

(2,373)

 

13,630

 

1,253,697

 

1,437,955

 

(6,913)

 

12,579

 

1,443,621

 

1,591,111

 

(8,829)

 

7,841

 

1,590,123

Prepaid expenses and other current assets

 

59,188

 

 

 

59,188

 

61,525

 

 

 

61,525

 

63,827

 

 

 

63,827

Total current assets

 

3,592,079

 

(34,145)

 

29,265

 

3,587,199

 

3,747,153

 

(40,425)

 

28,693

 

3,735,421

 

3,835,984

 

(43,747)

 

29,678

 

3,821,915

Property, plant and equipment, net

 

525,159

 

 

 

525,159

 

525,362

 

 

 

525,362

 

545,673

 

 

 

545,673

Deferred tax assets

 

227,239

 

7,792

 

 

235,031

 

220,532

 

9,042

 

 

229,574

 

212,407

 

9,673

 

 

222,080

Other

 

157,533

 

 

 

157,533

 

156,867

 

 

 

156,867

 

149,608

 

 

 

149,608

Total assets

$

4,502,010

$

(26,353)

$

29,265

$

4,504,922

$

4,649,914

$

(31,383)

$

28,693

$

4,647,224

$

4,743,672

$

(34,074)

$

29,678

$

4,739,276

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

$

1,694,592

$

$

13,630

$

1,708,222

$

1,817,465

$

$

12,579

$

1,830,044

$

1,976,533

$

$

7,841

$

1,984,374

Accrued liabilities

 

236,227

 

2,100

 

15,635

 

253,962

 

314,648

 

1,669

 

16,114

 

332,431

 

303,076

 

1,299

 

21,837

 

326,212

Accrued payroll and related benefits

 

115,738

 

 

 

115,738

 

116,794

 

 

 

116,794

 

133,319

 

 

 

133,319

Short-term debt, including current portion of long-term debt

 

18,750

 

 

 

18,750

 

18,750

 

 

 

18,750

 

18,750

 

 

 

18,750

Total current liabilities

 

2,065,307

 

2,100

 

29,265

 

2,096,672

 

2,267,657

 

1,669

 

28,693

 

2,298,019

 

2,431,678

 

1,299

 

29,678

 

2,462,655

Long-term liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Long-term debt

 

307,160

 

 

 

307,160

 

302,751

 

 

 

302,751

 

298,345

 

 

 

298,345

Other

 

248,326

 

 

 

248,326

 

241,416

 

 

 

241,416

 

209,716

 

 

 

209,716

Total long-term liabilities

 

555,486

 

 

 

555,486

 

544,167

 

 

 

544,167

 

508,061

 

 

 

508,061

Contingencies (Note 11)

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity

 

1,881,217

 

(28,453)

 

 

1,852,764

 

1,838,090

 

(33,052)

 

 

1,805,038

 

1,803,933

 

(35,373)

 

 

1,768,560

Total liabilities and stockholders’ equity

$

4,502,010

$

(26,353)

$

29,265

$

4,504,922

$

4,649,914

$

(31,383)

$

28,693

$

4,647,224

$

4,743,672

$

(34,074)

$

29,678

$

4,739,276

Consolidated Statements of Income

The following table presents the impact of the financial statement adjustments on the Company’s previously reported Consolidated Statements of Income for the three months ended January 1, 2022, April 2, 2022 and July 2, 2022.

Three Months Ended

January 1, 2022

April 2, 2022

July 2, 2022

    

Previously

Investigation

Other

Previously

Investigation

Other

Previously

Investigation

Other

    

 Reported

    

Adjustments

    

Adjustments

    

As Restated

    

 Reported

    

Adjustments

    

Adjustments

    

As Restated

    

 Reported

    

Adjustments

    

Adjustments

    

As Restated

(Unaudited) (In thousands)

Net sales

$

1,757,325

$

(999)

$

$

1,756,326

$

1,911,530

$

3,540

$

$

1,915,070

$

2,019,059

$

4,302

$

$

2,023,361

Cost of sales

 

1,612,836

 

2,193

 

 

1,615,029

 

1,759,083

 

9,492

 

 

1,768,575

 

1,853,870

 

7,306

 

 

1,861,176

Gross profit

 

144,489

 

(3,192)

 

 

141,297

 

152,447

 

(5,952)

 

 

146,495

 

165,189

 

(3,004)

 

 

162,185

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

61,475

 

 

 

61,475

 

61,817

 

 

 

61,817

 

61,506

 

 

 

61,506

Research and development

 

4,777

 

 

 

4,777

 

5,472

 

 

 

5,472

 

5,071

 

 

 

5,071

Restructuring and other

 

1,414

 

 

 

1,414

 

2,932

 

 

 

2,932

 

3,994

 

 

 

3,994

Gain on sale of long-lived assets

 

(4,610)

 

 

 

(4,610)

 

 

 

 

 

 

 

 

Total operating expenses

 

63,056

 

 

 

63,056

 

70,221

 

 

 

70,221

 

70,571

 

 

 

70,571

Operating income

 

81,433

 

(3,192)

 

 

78,241

 

82,226

 

(5,952)

 

 

76,274

 

94,618

 

(3,004)

 

 

91,614

 

Interest income

 

309

 

 

 

309

 

349

 

 

 

349

 

540

 

 

 

540

Interest expense

 

(4,877)

 

 

 

(4,877)

 

(4,870)

 

 

 

(4,870)

 

(5,615)

 

 

 

(5,615)

Other income (expense), net

 

2,072

 

 

 

2,072

 

(1,408)

 

 

 

(1,408)

 

(7,774)

 

 

 

(7,774)

Interest and other, net

 

(2,496)

 

 

 

(2,496)

 

(5,929)

 

 

 

(5,929)

 

(12,849)

 

 

 

(12,849)

Income before income taxes

 

78,937

 

(3,192)

 

 

75,745

 

76,297

 

(5,952)

 

 

70,345

 

81,769

 

(3,004)

 

 

78,765

Provision for income taxes

 

20,303

 

(735)

 

 

19,568

 

23,077

 

(1,353)

 

 

21,724

 

2,226

 

(683)

 

 

1,543

Net income

$

58,634

$

(2,457)

$

$

56,177

$

53,220

$

(4,599)

$

$

48,621

$

79,543

$

(2,321)

$

$

77,222

Net income per share:

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Basic

$

0.91

$

(0.04)

$

$

0.87

$

0.85

$

(0.08)

$

$

0.77

$

1.33

$

(0.04)

$

$

1.29

Diluted

$

0.89

$

(0.04)

$

$

0.85

$

0.83

$

(0.07)

$

$

0.76

$

1.29

$

(0.04)

$

$

1.25

The following table presents the impact of the financial statement adjustments on the Company’s previously reported Consolidated Statements of Income for the six and nine months ended April 2, 2022 and July 2, 2022, respectively.

Six Months Ended

Nine Months Ended

April 2, 2022

July 2, 2022

    

Previously

    

Investigation

    

Other

    

    

Previously

    

Investigation

    

Other

    

Reported

Adjustments

Adjustments

As Restated

Reported

Adjustments

Adjustments

As Restated

(Unaudited) (In thousands)

Net sales

$

3,668,855

$

2,541

$

$

3,671,396

$

5,687,914

$

6,843

$

$

5,694,757

Cost of sales

 

3,371,919

 

11,685

 

 

3,383,604

 

5,225,789

 

18,991

 

 

5,244,780

Gross profit

 

296,936

 

(9,144)

 

 

287,792

 

462,125

 

(12,148)

 

 

449,977

Operating expenses:

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Selling, general and administrative

 

123,292

 

 

 

123,292

 

184,798

 

 

 

184,798

Research and development

 

10,249

 

 

 

10,249

 

15,320

 

 

 

15,320

Restructuring and other

 

4,346

 

 

 

4,346

 

8,340

 

 

 

8,340

Gain on sale of long-lived assets

 

(4,610)

 

 

 

(4,610)

 

(4,610)

 

 

 

(4,610)

Total operating expenses

 

133,277

 

 

 

133,277

 

203,848

 

 

 

203,848

Operating income

 

163,659

 

(9,144)

 

 

154,515

 

258,277

 

(12,148)

 

 

246,129

Interest income

 

658

 

 

 

658

 

1,198

 

 

 

1,198

Interest expense

 

(9,747)

 

 

 

(9,747)

 

(15,362)

 

 

 

(15,362)

Other income (expense), net

 

664

 

 

 

664

 

(7,110)

 

 

 

(7,110)

Interest and other, net

 

(8,425)

 

 

 

(8,425)

 

(21,274)

 

 

 

(21,274)

Income before income taxes

 

155,234

 

(9,144)

 

 

146,090

 

237,003

 

(12,148)

 

 

224,855

Provision for income taxes

 

43,380

 

(2,088)

 

 

41,292

 

45,606

 

(2,771)

 

 

42,835

Net income

$

111,854

$

(7,056)

$

$

104,798

$

191,397

$

(9,377)

$

$

182,020

Net income per share:

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Basic

$

1.76

$

(0.11)

$

$

1.65

$

3.07

$

(0.15)

$

$

2.92

Diluted

$

1.71

$

(0.11)

$

$

1.60

$

2.98

$

(0.15)

$

$

2.83

Consolidated Statements of Cash Flows

The following table presents the impact of the financial statement adjustments on the Company’s previously reported Consolidated Statements of Cash Flows for the periods indicated below.

Three Months Ended

Six Months Ended

Nine Months Ended

January 1, 2022

April 2, 2022

July 2, 2022

Previously 

Investigation

Other

Previously 

Investigation

Other

Previously 

Investigation

Other

    

Reported

    

Adjustments

    

Adjustments

    

As Restated

    

Reported

    

Adjustments

    

Adjustments

    

As Restated

    

Reported

    

Adjustments

    

Adjustments

    

As Restated

(Unaudited) (In thousands)

CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:

    

  

    

  

    

  

    

  

    

  

    

  

    

  

    

  

    

  

Net income

$

58,634

$

(2,457)

$

$

56,177

$

111,854

$

(7,056)

$

$

104,798

$

191,397

$

(9,377)

$

$

182,020

Adjustments to reconcile net income to cash provided by operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

27,465

 

 

 

27,465

 

55,032

 

 

 

55,032

 

82,097

 

 

 

82,097

Stock-based compensation expense

 

9,032

 

 

 

9,032

 

18,362

 

 

 

18,362

 

29,045

 

 

 

29,045

Deferred income taxes

 

6,707

 

(648)

 

 

6,059

 

11,071

 

(1,898)

 

 

9,173

 

18,522

 

(2,529)

 

 

15,993

Impairment of goodwill and other assets

 

 

 

 

 

 

 

 

 

1,848

 

 

 

1,848

Loss on sale of intellectual property

Other, net

 

(3,638)

 

 

 

(3,638)

 

(1,903)

 

 

 

(1,903)

 

(3,146)

 

 

 

(3,146)

Changes in operating assets and liabilities, net of amounts acquired:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

(106,972)

 

 

316

 

(106,656)

 

(79,705)

 

 

397

 

(79,308)

 

(39,850)

 

 

(426)

 

(40,276)

Contract assets

 

(15,666)

 

3,064

 

(2,791)

 

(15,393)

 

(68,545)

 

4,804

 

(3,351)

 

(67,092)

 

(110,565)

 

6,210

 

(8,251)

 

(112,606)

Inventories

 

(207,300)

 

88

 

(6,066)

 

(213,278)

 

(403,396)

 

4,628

 

(5,015)

 

(403,783)

 

(559,118)

 

6,544

 

(277)

 

(552,851)

Prepaid expenses and other assets

 

(2,939)

 

 

 

(2,939)

 

(11,334)

 

 

 

(11,334)

 

(13,269)

 

 

 

(13,269)

Accounts payable

 

234,525

 

 

6,066

 

240,591

 

357,176

 

 

5,015

 

362,191

 

507,632

 

 

277

 

507,909

Accrued liabilities

 

68,452

 

(47)

 

2,475

 

70,880

 

158,661

 

(478)

 

2,954

 

161,137

 

144,363

 

(848)

 

8,677

 

152,192

Cash provided by operating activities

$

68,300

$

$

$

68,300

$

147,273

$

$

$

147,273

$

248,956

$

$

$

248,956

Consolidated Balance Sheets

The following table presents the impact of the financial statement adjustments on the Company’s previously reported Consolidated Balance Sheets as of January 2, 2021, April 3, 2021 and July 3, 2021.

As of

January 2, 2021

April 3, 2021

July 3, 2021

Previously 

Investigation

Other

Previously 

Investigation

Other

Previously 

Investigation

Other

    

Reported

    

Adjustments

    

Adjustments

    

As Restated

    

Reported

    

Adjustments

    

Adjustments

    

As Restated

    

Reported

    

Adjustments

    

Adjustments

    

As Restated

(Unaudited) (In thousands)

ASSETS

    

  

    

  

    

  

    

  

    

  

    

  

    

  

    

  

    

  

Current assets:

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Cash and cash equivalents

$

516,030

$

$

$

516,030

$

575,176

$

$

575,176

$

623,844

$

$

$

623,844

Accounts receivable, net of allowances

 

1,108,472

 

-

 

4,453

 

1,112,925

 

1,122,962

 

-

 

1,876

 

1,124,838

 

1,153,813

 

 

1,440

 

1,155,253

Contract assets

 

350,049

 

(9,427)

 

17,367

 

357,989

 

334,957

 

(27,204)

 

14,194

 

321,947

 

345,096

 

(29,357)

 

17,699

 

333,438

Inventories

 

819,474

 

 

 

819,474

 

785,406

 

 

 

785,406

 

892,633

 

 

 

892,633

Prepaid expenses and other current assets

 

48,851

 

 

 

48,851

 

38,584

 

 

 

38,584

 

50,446

 

 

 

50,446

Total current assets

 

2,842,876

 

(9,427)

 

21,820

 

2,855,269

 

2,857,085

 

(27,204)

 

16,070

 

2,845,951

 

3,065,832

 

(29,357)

 

19,139

 

3,055,614

Property, plant and equipment, net

 

541,188

 

-

 

(14,543)

 

526,645

 

529,651

 

-

 

(14,448)

 

515,203

 

550,038

 

 

(14,353)

 

535,685

Deferred tax assets

 

269,803

 

2,074

 

(690)

 

271,187

 

259,943

 

6,649

 

 

266,592

 

241,069

 

6,991

 

 

248,060

Other

 

125,867

 

-

 

14,543

 

140,410

 

123,550

 

-

 

14,448

 

137,998

 

145,651

 

 

14,353

 

160,004

Total assets

$

3,779,734

$

(7,353)

$

21,130

$

3,793,511

$

3,770,229

$

(20,555)

$

16,070

$

3,765,744

$

4,002,590

$

(22,366)

$

19,139

$

3,999,363

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

  

 

 

 

  

 

  

 

 

 

 

 

 

 

Current liabilities:

 

  

 

 

 

  

 

  

 

 

 

 

 

 

 

Accounts payable

$

1,143,431

$

$

$

1,143,431

$

1,108,994

$

$

$

1,108,994

$

1,296,005

$

$

$

1,296,005

Accrued liabilities

 

190,797

 

(136)

 

18,920

 

209,581

 

176,148

 

3,621

 

16,070

 

195,839

 

149,236

 

2,990

 

19,139

 

171,365

Accrued payroll and related benefits

 

120,469

 

 

 

120,469

 

114,704

 

 

 

114,704

 

123,365

 

 

 

123,365

Short-term debt, including current portion of long-term debt

 

18,750

 

 

 

18,750

 

18,750

 

 

 

18,750

 

18,750

 

 

 

18,750

Total current liabilities

 

1,473,447

 

(136)

 

18,920

 

1,492,231

 

1,418,596

 

3,621

 

16,070

 

1,438,287

 

1,587,356

 

2,990

 

19,139

 

1,609,485

Long-term liabilities:

 

  

 

 

 

  

 

  

 

 

 

 

 

 

 

Long-term debt

 

324,825

 

 

 

324,825

 

320,405

 

 

 

320,405

 

315,987

 

 

 

315,987

Other

 

303,514

 

 

 

303,514

 

296,121

 

 

 

296,121

 

260,132

 

 

 

260,132

Total long-term liabilities

 

628,339

 

 

 

628,339

 

616,526

 

 

 

616,526

 

576,119

 

 

 

576,119

Contingencies (Note 11)

 

  

 

 

 

  

 

  

 

 

 

 

 

 

 

Stockholders’ equity

 

1,677,948

 

(7,217)

 

2,210

 

1,672,941

 

1,735,107

 

(24,176)

 

 

1,710,931

 

1,839,115

 

(25,356)

 

 

1,813,759

Total liabilities and stockholders’ equity

$

3,779,734

$

(7,353)

$

21,130

$

3,793,511

$

3,770,229

$

(20,555)

$

16,070

$

3,765,744

$

4,002,590

$

(22,366)

$

19,139

$

3,999,363

Consolidated Statements of Income

The following table presents the impact of the financial statement adjustments on the Company’s previously reported Consolidated Statements of Income for the periods indicated below.

January 2, 2021

April 3, 2021

July 3, 2021

Previously 

Investigation

Other

Previously 

Investigation

Other

Previously 

Investigation

Other

    

Reported

Adjustments

Adjustments

    

As Restated

    

Reported

    

Adjustments

    

Adjustments

    

As Restated

    

Reported

    

Adjustments

    

Adjustments

    

As Restated

(Unaudited) (In thousands)

Net sales

    

$

1,755,249

    

$

735

$

    

$

1,755,984

    

$

1,699,677

    

$

(21,180)

$

    

$

1,678,497

    

$

1,657,741

    

$

(4,475)

$

    

$

1,653,266

Cost of sales

 

1,614,014

 

1,619

 

 

1,615,633

 

1,556,579

 

933

 

 

1,557,512

 

1,521,151

 

(2,951)

 

 

1,518,200

Gross profit

 

141,235

 

(884)

 

 

140,351

 

143,098

 

(22,113)

 

 

120,985

 

136,590

 

(1,524)

 

 

135,066

Operating expenses:

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Selling, general and administrative

 

58,967

 

 

 

58,967

 

61,142

 

 

 

61,142

 

57,438

 

 

 

57,438

Research and development

 

4,805

 

 

 

4,805

 

5,353

 

 

 

5,353

 

5,269

 

 

 

5,269

Restructuring and other

 

1,904

 

 

 

1,904

 

11,880

 

 

 

11,880

 

(382)

 

 

 

(382)

Total operating expenses

 

65,676

 

 

 

65,676

 

78,375

 

 

 

78,375

 

62,325

 

 

 

62,325

Operating income

 

75,559

 

(884)

 

 

74,675

 

64,723

 

(22,113)

 

 

42,610

 

74,265

 

(1,524)

 

 

72,741

Interest income

 

230

 

 

 

230

 

244

 

 

 

244

 

217

 

 

 

217

Interest expense

 

(4,954)

 

 

 

(4,954)

 

(4,880)

 

 

 

(4,880)

 

(4,823)

 

 

 

(4,823)

Other income (expense), net

 

1,867

 

 

2,900

 

4,767

 

6,143

 

 

(2,900)

 

3,243

 

29,258

 

 

 

29,258

Interest and other, net

 

(2,857)

 

 

2,900

 

43

 

1,507

 

 

(2,900)

 

(1,393)

 

24,652

 

 

 

24,652

Income before income taxes

 

72,702

 

(884)

 

2,900

 

74,718

 

66,230

 

(22,113)

 

(2,900)

 

41,217

 

98,917

 

(1,524)

 

 

97,393

Provision for income taxes

 

24,681

 

(211)

 

690

 

25,160

 

19,193

 

(5,154)

 

(690)

 

13,349

 

(18,458)

 

(344)

 

 

(18,802)

Net income

$

48,021

$

(673)

$

2,210

$

49,558

$

47,037

$

(16,959)

$

(2,210)

$

27,868

$

117,375

$

(1,180)

$

$

116,195

Net income per share:

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Basic

$

0.74

$

(0.01)

$

0.03

$

0.76

$

0.72

$

(0.26)

$

(0.03)

$

0.43

$

1.79

$

(0.01)

$

$

1.78

Diluted

$

0.72

$

(0.01)

$

0.03

$

0.74

$

0.70

$

(0.26)

$

(0.03)

$

0.42

$

1.74

$

(0.01)

$

$

1.73

Six Months Ended

Nine Months Ended

April 3, 2021

July 3, 2021

Previously

Investigation 

Other 

As

Previously 

Investigation

Other

As

 Reported

Adjustments

Adjustments

 Restated

Reported

 Adjustments

 Adjustments

Restated

(Unaudited) (In thousands)

Net sales

    

$

3,454,926

    

$

(20,445)

    

$

    

$

3,434,481

    

$

5,112,667

    

$

(24,920)

    

$

    

$

5,087,747

Cost of sales

 

3,170,593

 

2,552

 

 

3,173,145

 

4,691,744

 

(399)

 

 

 

4,691,345

Gross profit

 

284,333

 

(22,997)

 

 

261,336

 

420,923

 

(24,521)

 

 

 

396,402

Operating expenses:

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Selling, general and administrative

 

120,109

 

 

 

120,109

 

177,547

 

 

 

 

177,547

Research and development

 

10,158

 

 

 

10,158

 

15,427

 

 

 

 

15,427

Restructuring and other

 

13,784

 

 

 

13,784

 

13,402

 

 

 

 

13,402

Total operating expenses

 

144,051

 

 

 

144,051

 

206,376

 

 

 

 

206,376

Operating income

 

140,282

 

(22,997)

 

 

117,285

 

214,547

 

(24,521)

 

 

 

190,026

Interest income

 

474

 

 

 

474

 

691

 

 

 

 

691

Interest expense

 

(9,834)

 

 

 

(9,834)

 

(14,657)

 

 

 

 

(14,657)

Other income (expense), net

 

8,010

 

 

 

8,010

 

37,268

 

 

 

 

37,268

Interest and other, net

 

(1,350)

 

 

 

(1,350)

 

23,302

 

 

 

 

23,302

Income before income taxes

 

138,932

 

(22,997)

 

 

115,935

 

237,849

 

(24,521)

 

 

 

213,328

Provision for income taxes

 

43,874

 

(5,365)

 

 

38,509

 

25,416

 

(5,709)

 

 

 

19,707

Net income

$

95,058

$

(17,632)

$

$

77,426

$

212,433

$

(18,812)

$

 

$

193,621

Net income per share:

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Basic

$

1.46

$

(0.27)

$

$

1.19

$

3.25

$

(0.29)

$

 

$

2.96

Diluted

$

1.42

$

(0.26)

$

$

1.16

$

3.17

$

(0.28)

$

 

$

2.89

Consolidated Statements of Cash Flows

The following table presents the impact of the financial statement adjustments on the Company’s previously reported Consolidated Statements of Cash Flows for the periods indicated below.

Three Months Ended

Six Months Ended

Nine Months Ended

January 2, 2021

April 3, 2021

July 3, 2021

Previously 

Investigation

Other

Previously 

Investigation

Other

Previously 

Investigation

Other

    

Reported

    

Adjustments

    

Adjustments

    

As Restated

    

Reported

    

Adjustments

    

Adjustments

    

As Restated

    

Reported

    

Adjustments

    

Adjustments

    

As Restated

(Unaudited) (In thousands)

CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:

    

  

    

  

    

  

    

  

    

  

    

  

    

  

    

  

    

  

Net income

$

48,021

$

(673)

$

2,210

$

49,558

$

95,058

$

(17,632)

$

$

77,426

$

212,433

$

(18,812)

$

$

193,621

Adjustments to reconcile net income to cash provided by operating activities:

 

  

 

Depreciation and amortization

 

27,635

 

 

 

27,635

 

54,831

 

 

 

54,831

 

82,204

 

 

 

82,204

Stock-based compensation expense

 

8,208

 

 

 

8,208

 

17,432

 

 

 

17,432

 

26,147

 

 

 

26,147

Deferred income taxes

 

3,447

 

(279)

 

690

 

3,858

 

13,641

 

(4,854)

 

 

8,787

 

32,142

 

(5,196)

 

 

26,946

Gain on sale of intellectual property

 

 

 

 

 

 

 

 

 

(15,000)

 

 

 

(15,000)

Gain on liquidation of foreign entity

 

 

 

 

 

 

 

 

 

(8,263)

 

 

 

(8,263)

Impairment of goodwill and other asset

 

 

 

 

 

 

 

 

 

 

 

Other, net

 

(99)

 

 

 

(99)

 

(19)

 

 

 

(19)

 

(633)

 

 

 

(633)

Changes in operating assets and liabilities, net of amounts acquired:

 

Accounts receivable

 

(64,217)

 

 

(2,744)

 

(66,961)

 

(79,166)

 

 

(167)

 

(79,333)

 

(108,277)

 

 

269

 

(108,008)

Contract assets

 

46,534

 

(15,009)

 

(2,845)

 

28,680

 

61,626

 

2,768

 

328

 

64,722

 

51,487

 

4,921

 

(3,177)

 

53,231

Inventories

 

42,282

 

15,187

 

 

57,469

 

75,303

 

15,187

 

 

90,490

 

(22,606)

 

15,187

 

 

(7,419)

Prepaid expenses and other assets

 

(9,400)

 

706

 

 

(8,694)

 

1,359

 

706

 

 

2,065

 

(3,574)

 

706

 

 

(2,868)

Accounts payable

 

(66,657)

 

 

 

(66,657)

 

(99,525)

 

 

 

(99,525)

 

61,524

 

 

 

61,524

Accrued liabilities

 

26,057

 

68

 

2,689

 

28,814

 

2,360

 

3,825

 

(161)

 

6,024

 

(60,963)

 

3,194

 

2,908

 

(54,861)

Cash provided by operating activities

$

61,811

$

$

$

61,811

$

142,900

$

$

$

142,900

$

246,621

$

$

$

246,621